American Heart Association Scientific Session Articles
Explore special articles published online first to coincide with presentations at AHA American Heart Association’s Annual Scientific Session.
Related Articles
Heart failure drug may be ‘cardioprotective strategy’ for high-risk patients with cancer
CHICAGO — Treatment with the heart failure medication sacubitril/valsartan was associated with a lower risk for chemotherapy-related heart damage among high-risk patients with cancer, according…
The US Preventive Services Task Force and Precision Prevention
This Viewpoint summarizes how the US Preventive Services Task Force specifies target populations for its recommendations and highlights 3 problems—including exacerbation of health inequities—posed by…
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections
This consensus statement creates a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation…
Food access in formerly redlined neighborhoods tied to poor cardiometabolic health
CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart…
Hurricane Preparedness in Hospital Systems
This Viewpoint highlights 10 categories of recommendations for preparing for current and future hurricane seasons.
AI Devices in Neurology—Moving From Diagnosis to Prognosis
This Viewpoint describes considerations for regulatory oversight in the implementation of artificial intelligence–enabled prognostic devices.
Oral Muvalaplin for Lowering of Lipoprotein(a)
This randomized clinical trial assesses the effect of muvalaplin on lipoprotein(a) concentrations in patients with high baseline lipoprotein(a) levels and cardiovascular risk factors.
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
This phase 2 randomized clinical trial evaluates the optimal dose, dosing interval, and safety of zerlasiran, a small-interfering RNA targeting hepatic synthesis of apolipoprotein(a), to…
Semaglutide Eligibility Across All Current Indications for US Adults
This cross-sectional study uses National Health and Nutrition Examination Survey data to examine the number of US adults eligible for semaglutide across all current indications.
Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
This cohort study evaluated adoption rates of sodium-glucose cotransporter-2 inhibitors at US hospitals for patients with heart failure and mildly reduced or preserved left ventribular…